SPONSOR
Shanghai Yueyang Integrated Medicine Hospital
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Shanghai Yueyang Integrated Medicine Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Ischemic Stroke AIS, Statin Adverse Reaction, Cerebral Small Vessel Diseases.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Yueyang Integrated Medicine Hospital
How many clinical trials has Shanghai Yueyang Integrated Medicine Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shanghai Yueyang Integrated Medicine Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Acute Ischemic Stroke AIS, Statin Adverse Reaction, Cerebral Small Vessel Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Yueyang Integrated Medicine Hospital research focus on?
Shanghai Yueyang Integrated Medicine Hospital clinical trials span Acute Ischemic Stroke AIS, Statin Adverse Reaction, Cerebral Small Vessel Diseases. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Yueyang Integrated Medicine Hospital clinical trial?
To participate in a Shanghai Yueyang Integrated Medicine Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Yueyang Integrated Medicine Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Yueyang Integrated Medicine Hospital
NCT07003386 Phase 2, Phase 3
Recruiting
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
Acute Ischemic Stroke AIS
NCT06592196
Recruiting
Hepatic Safety of Statin Use in Neurology Inpatients
Statin Adverse Reaction
NCT05985213
Recruiting
Cohort Study of Inpatients and Outpatient Patients With Cerebral Small Vessel Disease
Cerebral Small Vessel Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology